Search Results 1171-1180 of 18734 for Relapse

  1. Efficacy And Safety Of Nemtabrutinib (MK-1026) In Participants With Hematologic Malignancies (MK-1026-003) - Mayo Clinic

    ... relapsed or refractory following at least 1 line of prior therapy * Part 2 Cohort J: CLL/SLL participants whose disease relapsed or was refractory to prior ...

  2. CAR-T cell therapy - Care at Mayo Clinic

    Mayo Clinic researchers link CAR-T cell aging to cancer relapse · Mayo Clinic Q&A: What should I know about today's chemotherapy? Mayo Clinic Q&A ...

  3. Graft-Versus-Host Disease Clinical Trials - Mayo Clinic Research

    This study aims to determine if any of three new GVHD prophylaxis approaches improves the rate of GVHD and relapse free survival at one year after ...

  4. A Study to Evaluate Tadalafil and Lenalidomide with or without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk Myeloma - Mayo Clinic

    Relapsed myeloma patients that have not previously had a transplant. Meeting criteria for high-risk disease. Measurable serum and/or urine M-protein from ...

  5. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies - Mayo Clinic

    ... relapsed with no available curative options. Part 2 (Cohort Expansion): At ... Part 1 (Dose Escalation): Hematological malignancy has been previously treated, has ...

  6. Teen depression - Symptoms and causes - Mayo Clinic

    Maintain ongoing treatment, if recommended, even after symptoms let up, to help prevent a relapse of depression symptoms. By Mayo Clinic Staff · Teen ...

  7. Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Estrogen Receptor Positive (ER+) Breast Cancer - Mayo Clinic

    AI failures: Disease that relapsed during treatment or within 12 months of completion of adjuvant therapy with an AI, OR disease that progressed during ...

  8. Dr. Dean Wingerchuk Archives - Mayo Clinic News Network

    ... relapse, disability can worsen. It affects up to 10 in 100,000 people. Currently, the immunosuppressive therapies used to prevent neuromyelitis optica relapses ...

  9. Overview - Lymphoma Epidemiology Laboratory - Mayo Clinic Research

    Clinical trials. Mayo Clinic offers numerous studies for lymphoma and chronic lymphocytic leukemia, including studies on medications, relapsed cancer, advanced ...

  10. Study of BMF-219, in Adult Patients With Acute Leukemia (AL), Diffuse Large B-cell Lymphoma (DLBCL), Multiple Myeloma (MM), and Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) - Mayo Clinic

    Cohort 1 only: Refractory or relapsed acute leukemia defined as > 5% blasts in the bone marrow or reappearance of blasts in the peripheral blood. 2. Cohort ...